MDPI and ACS Style
Bruyère, C.L.d.l.; Souquet, P.-J.; Dalle, S.; Corbaux, P.; Boespflug, A.; Duruisseaux, M.; Kiakouama-Maleka, L.; Reverdy, T.; Maugeais, M.; Sahin, G.;
et al. Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers 2021, 13, 2365.
https://doi.org/10.3390/cancers13102365
AMA Style
Bruyère CLdl, Souquet P-J, Dalle S, Corbaux P, Boespflug A, Duruisseaux M, Kiakouama-Maleka L, Reverdy T, Maugeais M, Sahin G,
et al. Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers. 2021; 13(10):2365.
https://doi.org/10.3390/cancers13102365
Chicago/Turabian Style
Bruyère, Charline Lafayolle de la, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibaut Reverdy, Madeleine Maugeais, Gulsum Sahin,
and et al. 2021. "Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes" Cancers 13, no. 10: 2365.
https://doi.org/10.3390/cancers13102365